Hememics Biotechnologies, INC.
Biotechnology Firm
Based in MD
🤖
AI Overview
With $100K in lobbying spend across 9 quarterly filings, Hememics Biotechnologies, INC is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2020 to 2023.
$100K
Total Spend
4
Years Active
1
Firms Hired
1
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $20K |
| 2021 | $40K |
| 2022 | $10K |
| 2023 | $30K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, MED
- •Next generation diagnostic testing, COVID funding
- •COVID Stimulus Funding for Diagnostics and LHHS Next Generation Diagnostic Funding
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.